Filters

Year

Author

Publication type

Journal

Publications

Tripodo C, Florena AM, Iannitto E, Franco V

Reply to Pich et al.: intrasinusoidal bone marrow infiltration and splenic marginal zone lymphoma: a quantitative study.

Eur J Haematol 2006; 360; author reply 361. doi: 10.1111/j.1600-0609.2006.00726.x

Leggi ora

Tripodo C, Florena AM, Porcasi R, Ingrao S, Guarnotta C, Franco V

Constant detection of cyclooxygenase 2 in terminal stages of myeloid maturation.

Acta Haematol 2007; 48-50. doi: 10.1159/000096788

Leggi ora

Cabibi D, Di Vita G, La Spada E, Tripodo C, Patti R, Montalto G

Thyroid sarcoidosis as a unique localization.

Thyroid 2006; 1175-7. doi: 10.1089/thy.2006.16.1175

Leggi ora

Cabibi D, Mustacchio V, Martorana A, Tripodo C, Campione M, Calascibetta A, Sanguedolce R, Aragona F

Lymph node metastases displaying lower Ki-67 immunostaining activity than the primary breast cancer.

Anticancer Res 2006; 4357-60.

Leggi ora

Tripodo C, Porcasi R, Guarnotta C, Ingrao S, Campisi V, Florena AM, Franco V

C1q production by bone marrow stromal cells.

Scand J Immunol 2007; 308-9. doi: 10.1111/j.1365-3083.2006.01871.x

Leggi ora

Giannola LI, De Caro V, Giandalia G, Siragusa MG, Tripodo C, Florena AM, Campisi G

Release of naltrexone on buccal mucosa: permeation studies, histological aspects and matrix system design.

Eur J Pharm Biopharm 2007; 425-33. doi: 10.1016/j.ejpb.2007.02.020

Leggi ora

Cabibi D, Giovannelli L, Martorana A, Migliore MC, Tripodo C, Campione M, Ammatuna P, Aragona F

Predictive role of histological features and Ki67 pattern on high-risk HPV presence in atypical cervical lesions.

Histopathology 2007; 713-6. doi: 10.1111/j.1365-2559.2007.02832.x

Leggi ora

Macor P, Tripodo C, Zorzet S, Piovan E, Bossi F, Marzari R, Amadori A, Tedesco F

In vivo targeting of human neutralizing antibodies against CD55 and CD59 to lymphoma cells increases the antitumor activity of rituximab.

Cancer Res 2007; 10556-63. doi: 10.1158/0008-5472.CAN-07-1811

Leggi ora

Iannitto E, Minardi V, Tripodo C

Use of intrapleural bortezomib in myelomatous pleural effusion.

Br J Haematol 2007; 621-2. doi: 10.1111/j.1365-2141.2007.06735.x

Leggi ora

Florena AM, Tripodo C, Guarnotta C, Ingrao S, Porcasi R, Martorana A, Lo Bosco G, Cabibi D, Franco V

Associations between Notch-2, Akt-1 and HER2/neu expression in invasive human breast cancer: a tissue microarray immunophenotypic analysis on 98 patients.

Pathobiology 2007; 317-22. doi: 10.1159/000110024

Leggi ora

Bulla R, Agostinis C, Bossi F, Rizzi L, Debeus A, Tripodo C, Radillo O, De Seta F, Ghebrehiwet B, Tedesco F

Decidual endothelial cells express surface-bound C1q as a molecular bridge between endovascular trophoblast and decidual endothelium.

Mol Immunol 2008; 2629-40. doi: 10.1016/j.molimm.2007.12.025

Leggi ora

Todaro M, Alea MP, Di Stefano AB, Cammareri P, Vermeulen L, Iovino F, Tripodo C, Russo A, Gulotta G, Medema JP, Stassi G

Colon cancer stem cells dictate tumor growth and resist cell death by production of interleukin-4.

Cell Stem Cell 2007; 389-402. doi: 10.1016/j.stem.2007.08.001

Leggi ora

Ballarò B, Florena AM, Franco V, Tegolo D, Tripodo C, Valenti C

An automated image analysis methodology for classifying megakaryocytes in chronic myeloproliferative disorders.

Med Image Anal 2008; 703-12. doi: 10.1016/j.media.2008.04.001

Leggi ora

Iannitto E, Ferreri AJ, Minardi V, Tripodo C, Kreipe HH

Angioimmunoblastic T-cell lymphoma.

Crit Rev Oncol Hematol 2008; 264-71. doi: 10.1016/j.critrevonc.2008.06.012

Leggi ora

Macor P, Secco E, Zorzet S, Tripodo C, Celeghini C, Tedesco F

An update on the xenograft and mouse models suitable for investigating new therapeutic compounds for the treatment of B-cell malignancies.

Curr Pharm Des 2008; 2023-39. doi: 10.2174/138161208785294591

Leggi ora

Gri G, Piconese S, Frossi B, Manfroi V, Merluzzi S, Tripodo C, Viola A, Odom S, Rivera J, Colombo MP, Pucillo CE

CD4+CD25+ regulatory T cells suppress mast cell degranulation and allergic responses through OX40-OX40L interaction.

Immunity 2008; 771-81. doi: 10.1016/j.immuni.2008.08.018

Leggi ora

Tripodo C, Di Bernardo A, Ternullo MP, Guarnotta C, Porcasi R, Ingrao S, Gianelli U, Boveri E, Iannitto E, Franco G, Florena AM

CD146(+) bone marrow osteoprogenitors increase in the advanced stages of primary myelofibrosis.

Haematologica 2009; 127-30. doi: 10.3324/haematol.13598

Leggi ora

Biffi S, Garrovo C, Macor P, Tripodo C, Zorzet S, Secco E, Tedesco F, Lorusso V

In vivo biodistribution and lifetime analysis of cy5.5-conjugated rituximab in mice bearing lymphoid tumor xenograft using time-domain near-infrared optical imaging.

Mol Imaging 2008; 272-82.

Leggi ora

Campisi G, Paderni C, Saccone R, Siragusa MG, Lo Muzio L, Tripodo C, Giannola LI, Florena AM

Carbamazepine transbuccal delivery: the histo-morphological features of reconstituted human oral epithelium and buccal porcine mucosae in the transmucosal permeation.

Int J Immunopathol Pharmacol 2008; 903-10. doi: 10.1177/039463200802100414

Leggi ora

Corallini F, Bossi F, Gonelli A, Tripodo C, Castellino G, Mollnes TE, Tedesco F, Rizzi L, Trotta F, Zauli G, Secchiero P

The soluble terminal complement complex (SC5b-9) up-regulates osteoprotegerin expression and release by endothelial cells: implications in rheumatoid arthritis.

Rheumatology (Oxford) 2009; 293-8. doi: 10.1093/rheumatology/ken495

Leggi ora

Bossi F, Rizzi L, Bulla R, Debeus A, Tripodo C, Picotti P, Betto E, Macor P, Pucillo C, Würzner R, Tedesco F

C7 is expressed on endothelial cells as a trap for the assembling terminal complement complex and may exert anti-inflammatory function.

Blood 2009; 3640-8. doi: 10.1182/blood-2008-03-146472

Leggi ora

Tarantino G, Marco VD, Petta S, Almasio PL, Barbaria F, Licata A, Bosco GL, Tripodo C, Stefano RD, Craxì A

Serum BLyS/BAFF predicts the outcome of acute hepatitis C virus infection.

J Viral Hepat 2009; 397-405. doi: 10.1111/j.1365-2893.2009.01093.x

Leggi ora

Secchiero P, Sblattero D, Chiaruttini C, Melloni E, Macor P, Zorzet S, Tripodo C, Tedesco F, Marzari R, Zauli G

Selection and characterization of a novel agonistic human recombinant anti-TRAIL-R2 minibody with anti-leukemic activity.

Int J Immunopathol Pharmacol 2009; 73-83. doi: 10.1177/039463200902200109

Leggi ora

Florena AM, Tripodo C, Di Bernardo A, Iannitto E, Guarnotta C, Porcasi R, Ingrao S, Abbadessa V, Franco V

Different immunophenotypical apoptotic profiles characterise megakaryocytes of essential thrombocythaemia and primary myelofibrosis.

J Clin Pathol 2009; 331-8. doi: 10.1136/jcp.2007.054353

Leggi ora

Ciccia F, Bombardieri M, Principato A, Giardina A, Tripodo C, Porcasi R, Peralta S, Franco V, Giardina E, Craxi A, Pitzalis C, Triolo G

Overexpression of interleukin-23, but not interleukin-17, as an immunologic signature of subclinical intestinal inflammation in ankylosing spondylitis.

Arthritis Rheum 2009; 955-65. doi: 10.1002/art.24389

Leggi ora

Zucchetto A, Benedetti D, Tripodo C, Bomben R, Dal Bo M, Marconi D, Bossi F, Lorenzon D, Degan M, Rossi FM, Rossi D, Bulian P, Franco V, Del Poeta G, Deaglio S, Gaidano G, Tedesco F, Malavasi F, Gattei V

CD38/CD31, the CCL3 and CCL4 chemokines, and CD49d/vascular cell adhesion molecule-1 are interchained by sequential events sustaining chronic lymphocytic leukemia cell survival.

Cancer Res 2009; 4001-9. doi: 10.1158/0008-5472.CAN-08-4173

Leggi ora

Iannitto E, Minardi V, Gobbi PG, Calvaruso G, Tripodo C, Marcheselli L, Luminari S, Merli F, Baldini L, Stelitano C, Callea V, Petrini M, Angrilli F, Quarta G, Vallisa D, Molica S, Liardo E, Polimeno G, Brugiatelli M, Federico M

Response-guided ABVD chemotherapy plus involved-field radiation therapy for intermediate-stage Hodgkin lymphoma in the pre-positron emission tomography era: a Gruppo Italiano Studio Linfomi (GISL) prospective trial.

Clin Lymphoma Myeloma 2009; 138-44. doi: 10.3816/CLM.2009.n.034

Leggi ora

Tripodo C, Florena AM, Macor P, Di Bernardo A, Porcasi R, Guarnotta C, Ingrao S, Zerilli M, Secco E, Todaro M, Tedesco F, Franco V

P-selectin glycoprotein ligand-1 as a potential target for humoral immunotherapy of multiple myeloma.

Curr Cancer Drug Targets 2009; 617-25. doi: 10.2174/156800909789056971

Leggi ora

Piconese S, Gri G, Tripodo C, Musio S, Gorzanelli A, Frossi B, Pedotti R, Pucillo CE, Colombo MP

Mast cells counteract regulatory T-cell suppression through interleukin-6 and OX40/OX40L axis toward Th17-cell differentiation.

Blood 2009; 2639-48. doi: 10.1182/blood-2009-05-220004

Leggi ora

Giannitrapani L, Soresi M, La Spada E, Tripodo C, Montalto G

Progressive visceral leishmaniasis misdiagnosed as cirrhosis of the liver: a case report.

J Med Case Rep 2009; 7265. doi: 10.4076/1752-1947-3-7265

Leggi ora

Tripodo C, Iannitto E, Florena AM, Pucillo CE, Piccaluga PP, Franco V, Pileri SA

Gamma-delta T-cell lymphomas.

Nat Rev Clin Oncol 2009; 707-17. doi: 10.1038/nrclinonc.2009.169

Leggi ora

Merluzzi S, Frossi B, Gri G, Parusso S, Tripodo C, Pucillo C

Mast cells enhance proliferation of B lymphocytes and drive their differentiation toward IgA-secreting plasma cells.

Blood 2010; 2810-7. doi: 10.1182/blood-2009-10-250126

Leggi ora

Frossi B, Gri G, Tripodo C, Pucillo C

Exploring a regulatory role for mast cells: 'MCregs'?

Trends Immunol 2010; 97-102. doi: 10.1016/j.it.2009.12.007

Leggi ora

Pietrantonio F, Vernieri C, Siravegna G, Mennitto A, Berenato R, Perrone F, Gloghini A, Tamborini E, Lonardi S, Morano F, Picciani B, Busico A, Volpi CC, Martinetti A, Battaglin F, Bossi I, Pellegrinelli A, Milione M, Cremolini C, Di Bartolomeo M, Bardelli A, de Braud F

Heterogeneity of Acquired Resistance to Anti-EGFR Monoclonal Antibodies in Patients with Metastatic Colorectal Cancer.

Clin Cancer Res 2017; 2414-2422. doi: 10.1158/1078-0432.CCR-16-1863

Leggi ora

Oddo D, Siravegna G, Gloghini A, Vernieri C, Mussolin B, Morano F, Crisafulli G, Berenato R, Corti G, Volpi CC, Buscarino M, Niger M, Dunne PD, Rospo G, Valtorta E, Bartolini A, Fucà G, Lamba S, Martinetti A, Di Bartolomeo M, de Braud F, Bardelli A, Pietrantonio F, Di Nicolantonio F

Emergence of MET hyper-amplification at progression to MET and BRAF inhibition in colorectal cancer.

Br J Cancer 2017; 347-352. doi: 10.1038/bjc.2017.196

Leggi ora

Santaguida S, Vernieri C, Villa F, Ciliberto A, Musacchio A

Evidence that Aurora B is implicated in spindle checkpoint signalling independently of error correction.

EMBO J 2011; 1508-19. doi: 10.1038/emboj.2011.70

Leggi ora

Vernieri C, Chiroli E, Francia V, Gross F, Ciliberto A

Adaptation to the spindle checkpoint is regulated by the interplay between Cdc28/Clbs and PP2ACdc55.

J Cell Biol 2013; 765-78. doi: 10.1083/jcb.201303033

Leggi ora

Bonaiuti P, Chiroli E, Gross F, Corno A, Vernieri C, Štefl M, Cosentino Lagomarsino M, Knop M, Ciliberto A

Cells Escape an Operational Mitotic Checkpoint through a Stochastic Process.

Curr Biol 2018; 28-37.e7. doi: 10.1016/j.cub.2017.11.031

Leggi ora

Corno A, Chiroli E, Gross F, Vernieri C, Matafora V, Maffini S, Cosentino Lagomarsino M, Bachi A, Ciliberto A

Cellular response upon proliferation in the presence of an active mitotic checkpoint.

Life Sci Alliance 2019; . doi: 10.26508/lsa.201900380

Leggi ora

Ajazi A, Bruhn C, Shubassi G, Lucca C, Ferrari E, Cattaneo A, Bachi A, Manfrini N, Biffo S, Martini E, Minucci S, Vernieri C, Foiani M

Endosomal trafficking and DNA damage checkpoint kinases dictate survival to replication stress by regulating amino acid uptake and protein synthesis.

Dev Cell 2021; 2607-2622.e6. doi: 10.1016/j.devcel.2021.08.019

Leggi ora

Pupa SM, Ligorio F, Cancila V, Franceschini A, Tripodo C, Vernieri C, Castagnoli L

HER2 Signaling and Breast Cancer Stem Cells: The Bridge behind HER2-Positive Breast Cancer Aggressiveness and Therapy Refractoriness.

Cancers (Basel) 2021; . doi: 10.3390/cancers13194778

Leggi ora

Castagnoli L, Franceschini A, Cancila V, Dugo M, Bigliardi M, Chiodoni C, Toneguzzo P, Regondi V, Corsetto PA, Pietrantonio F, Mazzucchelli S, Corsi F, Belfiore A, Vingiani A, Pruneri G, Ligorio F, Colombo MP, Tagliabue E, Tripodo C, Vernieri C, Triulzi T, Pupa SM